Report - Olivia Pagani Breast Unit and Institute of Oncology of ... · max 10%. for higher composite risks. Exemestane+OFS. Tamoxifen+OFS. Tamoxifen. STEPP of 8-yr Freedom from Distant Recurrence

Please pass captcha verification before submit form